Aptevo Therapeutics (APVO) CFO exercises 638 RSUs into common stock
Rhea-AI Filing Summary
Aptevo Therapeutics Inc. reported that SVP & CFO Daphne Taylor exercised 638 Restricted Stock Units on August 6, 2026. The RSUs converted into 638 shares of common stock on a one-for-one basis. These RSUs originated from an August 6, 2025 grant of 11,500 RSUs (638 post-split) that vested on the first anniversary of the grant date.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 638 shares
Net Buy
2 txns
Insider
Taylor Daphne
Role
SVP, CFO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit F1, F2 | 638 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 638 | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 0 shares (Direct);
Common Stock — 638 shares (Direct)
Footnotes (2)
- F1. Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- F2. On August 6, 2025, the reporting person was granted 11,500 (638 post-split) RSUs, vesting on the first anniversary of the date of grant.
Key Figures
RSUs exercised: 638 Restricted Stock Units
Common shares acquired: 638 shares
Original RSU grant: 11,500 RSUs (638 post-split)
+2 more
5 metrics
RSUs exercised
638 Restricted Stock Units
Converted into common stock on August 6, 2026
Common shares acquired
638 shares
One-for-one conversion of vested RSUs
Original RSU grant
11,500 RSUs (638 post-split)
Granted to Daphne Taylor on August 6, 2025
Per-share transaction price
$0.0000 per share
Reported for the RSU conversion transaction
Shares held after transaction
638 shares
Direct ownership of common stock following RSU conversion
Key Terms
Restricted Stock Unit, derivative security, par value
3 terms
Restricted Stock Unit financial
"Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
par value financial
"common stock, $0.001 par value per share, of the Issuer"
Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Aptevo Therapeutics (APVO) report for Daphne Taylor?
Aptevo Therapeutics reported that SVP & CFO Daphne Taylor exercised 638 RSUs, which converted into 638 shares of common stock on August 6, 2026, following the vesting of a prior RSU grant.
What was the origin of the 638 RSUs exercised at Aptevo Therapeutics (APVO)?
The 638 RSUs exercised by Daphne Taylor came from an August 6, 2025 grant of 11,500 RSUs (shown as 638 post-split), which were scheduled to vest on the first anniversary of the grant date.
What type of securities were involved in the Aptevo Therapeutics (APVO) Form 4?
The Form 4 reports activity in Restricted Stock Units that are a derivative security and their conversion into common stock of Aptevo Therapeutics on a one-for-one basis.